Orlena Tam

Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models

S. Thorne, P. Working, T. Reid, 2005, Clinical Cancer Research.